For some experiments recombinant mouse IL-10 was added to T-cell cultures (1 ng/ml; eBioscience). Proliferation was assessed by pulsing cultures overnight with 0·5 μCi/well of [3H]thymidine overnight and performing scintillation counts. Culture supernatants were harvested daily over 4 days. Expression levels of interferon-γ, IL-2, IL-4, IL-5, IL-10, IL-17 and tumour necrosis selleck screening library factor-α in supernatant samples were quantified by means of a cytofluorimetry-based ELISA system according to the manufacturer’s instructions (Flowcytomix; Bender Medsystem GmbH, Vienna, Austria). Cells were suspended in
FACS buffer (3% fetal calf serum, 5 mm EDTA in PBS). Cells were incubated with conjugated monoclonal antibodies in the presence of Fc blockers (clone 2.4G2). All data acquisition was performed on a FACSCalibur flow cytometer (Becton-Dickinson, San Jose, CA). The anti-mouse monoclonal antibodies used (Becton-Dickinson) were: CD4-FITC, CD44-phycoerythrin, CD62L-peridinin chlorophyll protein complex, CD25-allophycocyanin and Foxp3-phycoerythrin. T cells Saracatinib nmr were identified as CD3+ and either CD4+ CD8− for CD4 T cells or CD4− CD8+ for CD8+ T cells. CD44, CD62L and CD25 expression was used to assess
T-cell activation status. For FACS, regulatory T (Treg) cells were characterized as CD4+ CD44intermediate/high CD25+ cells.12 All values were expressed as the mean ± standard error of the mean (SEM). Statistical analysis was calculated by the two-tailed unpaired t-test using graphpad prism software (GraphPad Software, La Jolla, CA). A P-value < 0·05 was considered statistically significant. To confirm that the proliferation inhibition observed among ASC−/− CD3+ T cells in response to anti-CD3/CD28 stimulation9 is specifically linked to ASC deficiency and so not a consequence of a general NALP3 inflammasome dysfunction, we initially compared the proliferative response
of ASC−/− and NALP3−/− CD3+ T cells. When compared with ASC−/− CD3+ T cells, NALP3−/− CD3+ T cells did not display an impaired proliferative Liothyronine Sodium response to anti-CD3/CD28 stimulation (Fig. 1a), suggesting that this ASC-associated T-cell defect is NALP3 inflammasome-independent. We next investigated whether this ASC−/− T-cell phenomenon is restricted to a specific T-cell subset or if it affects T cells more globally. Therefore purified CD4+ and CD8+ T cells from ASC+/+ and ASC−/− mice were stimulated separately with plate-bound anti-CD3/CD28 and their proliferation was assessed over time. When compared with similarly stimulated WT controls, ASC−/− CD4+ (Fig. 1b) and CD8+ (Fig. 1c) T cells displayed no impairment in their proliferative response upon activation. Furthermore, no alteration in the regulation of T-cell activation markers (CD44, CD62L and CD25) was observed on ASC−/− CD4+ (Fig. 1d) and CD8+ (Fig. 1e) T cells following activation compared with WT controls.